Transcriptome analysis in patients with progressive coronary artery disease: Identification of differential gene expression in peripheral blood

Journal of Cardiovascular Translational Research

Volumn 6, Issue 1, 2013, Pages 81-93

  Nührenberg, Thomas G ^a   Langwieser, Nicole ^b,c   Binder, Harald ^d,e   Kurz, Thorsten ^f   Stratz, Christian ^a   Kienzle, Rolf Peter ^a   Trenk, Dietmar ^a   Zohlnhöfer Momm, Dietlind ^b,c   Neumann, Franz Josef ^a  

^a UNIVERSITY HEART CENTER FREIBURG BAD KROZINGEN   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c Berlin Brandenburg Center for Regenerative Therapies   (Germany)

^d UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^e UNIVERSITY OF FREIBURG   (Germany)

^f UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Atherosclerosis; Coronary artery disease; Gene expression; Plaque progression

Indexed keywords

ANKYRIN; ANKYRIN 2; GLUTATHIONE TRANSFERASE T1; TRANSCRIPTOME; UNCLASSIFIED DRUG;

AGED; ANGIOCARDIOGRAPHY; ANK2 GENE; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BLOOD ANALYSIS; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CORONARY ARTERY DISEASE; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; DISEASE CONTROL; DISEASE COURSE; FEMALE; FLYWCH1 GENE; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GSTT1 GENE; HUMAN; MALE; NUCLEOTIDE SEQUENCE; PATIENT IDENTIFICATION; PERCUTANEOUS CORONARY INTERVENTION; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REPEAT PROCEDURE; RISK ASSESSMENT; RNA ANALYSIS; SENSITIVITY AND SPECIFICITY; STEM CELL; VALIDATION PROCESS;

AGED; ANKYRINS; CLUSTER ANALYSIS; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY VESSELS; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION PROFILING; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GLUTATHIONE TRANSFERASE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENOTYPE; PLAQUE, ATHEROSCLEROTIC; POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; RISK FACTORS;

EID: 84872604915     PISSN: 19375387     EISSN: 19375395     Source Type: Journal    
DOI: 10.1007/s12265-012-9420-5     Document Type: Article

References (32)

1. Lusis, A. J. (2000). Atherosclerosis. Nature, 407, 233-241.
2. Hansson, G. K. (2005). Inflammation, atherosclerosis, and coronary artery disease. The New England Journal of Medicine, 352, 1685-1695. (Pubitemid 40530235)
3. Libby, P. (2002). Inflammation in atherosclerosis. Nature, 420, 868-874. (Pubitemid 36019640)
4. Libby, P; & Theroux, P. (2005). Pathophysiology of coronary artery disease. Circulation, 111, 3481-3488. (Pubitemid 40923403)
5. Baigent, C; Blackwell, L; Emberson, J; Holland, L. E; Reith, C; Bhala, N; et al. (2010). Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet, 376, 1670-1681.
6. Kwak, B; Mulhaupt, F; Myit, S; & Mach, F. (2000). Statins as a newly recognized type of immunomodulator. Nature Medicine, 6, 1399-1402. (Pubitemid 32001026)
7. Austen, W. G; Edwards, J. E; Frye, R. L; Gensini, G. G; Gott, V. L; Griffith, L. S; et al. (1975). A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association. Circulation, 51, 5-40.
8. Bestehorn, H. P; Neumann, F. J; Buttner, H. J; Betz, P; Sturzenhofecker, P; von Hodenberg, E; et al. (2004). Evaluation of the effect of oral verapamil on clinical outcome and angiographic restenosis after percutaneous coronary intervention: the randomized, double-blind, placebo-controlled, multicenter Verapamil Slow-Release for Prevention of Cardiovascular Events After Angioplasty (VESPA) Trial. Journal of the American College of Cardiology, 43, 2160-2165. (Pubitemid 38765106)
9. Ringqvist, I; Fisher, L. D; Mock, M; Davis, K. B; Wedel, H; Chaitman, B. R; et al. (1983). Prognostic value of angiographic indices of coronary artery disease from the Coronary Artery Surgery Study (CASS). The Journal of Clinical Investigation, 71, 1854-1866. (Pubitemid 13056789)
10. Benjamini, Y; & Hochberg, Y. (1995). Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society: Series B: Methodological, 57, 289-300.
11. Eisen, M. B; Spellman, P. T; Brown, P. O; & Botstein, D. (1998). Cluster analysis and display of genome-wide expression patterns. Proceedings of the National Academy of Sciences of the United States of America, 95, 14863-14868. (Pubitemid 29003722)
12. Dennis, G; Jr; Sherman, B. T; Hosack, D. A; Yang, J; Gao, W; Lane, H. C; et al. (2003). DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biology, 4, P3.
13. Eden, E; Navon, R; Steinfeld, I; Lipson, D; & Yakhini, Z. (2009). GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists. BMC Bioinformatics, 10, 48.
14. Tutz, G; & Binder, H. (2007). Boosting ridge regression. Computational Statistics & Data Analysis, 51, 6044-6059. (Pubitemid 47126005)
15. Binder, H; & Schumacher, M. (2008). Adapting prediction error estimates for biased complexity selection in high-dimensional bootstrap samples. Statistical Applications in Genetics and Molecular Biology, 7, 12.
16. Schmittgen, T. D; & Livak, K. J. (2008). Analyzing real-time PCR data by the comparative C(T) method. Nature Protocols, 3, 1101-1108. (Pubitemid 351818697)
17. Mohr, S; & Liew, C. C. (2007). The peripheral-blood transcriptome: new insights into disease and risk assessment. Trends in Molecular Medicine, 13, 422-432. (Pubitemid 47562311)
18. Ma, J; & Liew, C. C. (2003). Gene profiling identifies secreted protein transcripts from peripheral blood cells in coronary artery disease. Journal of Molecular and Cellular Cardiology, 35, 993-998. (Pubitemid 36871024)
19. Sinnaeve, P. R; Donahue, M. P; Grass, P; Seo, D; Vonderscher, J; Chibout, S. D; et al. (2009). Gene expression patterns in peripheral blood correlate with the extent of coronary artery disease. PloS One, 4, e7037.
20. Patino, W. D; Mian, O. Y; Kang, J. G; Matoba, S; Bartlett, L. D; Holbrook, B; et al. (2005). Circulating transcriptome reveals markers of atherosclerosis. Proceedings of the National Academy of Sciences of the United States of America, 102, 3423-3428. (Pubitemid 40328061)
21. Wingrove, J. A; Daniels, S. E; Sehnert, A. J; Tingley, W; Elashoff, M. R; Rosenberg, S; et al. (2008). Correlation of peripheral-blood gene expression with the extent of coronary artery stenosis. Circulation. Cardiovascular Genetics, 1, 31-38.
22. Ma, J; Dempsey, A. A; Stamatiou, D; Marshall, K. W; & Liew, C. C. (2007). Identifying leukocyte gene expression patterns associated with plasma lipid levels in human subjects. Atherosclerosis, 191, 63-72. (Pubitemid 46227430)
23. Timofeeva, A. V; Goryunova, L. E; Khaspekov, G. L; Kovalevskii, D. A; Scamrov, A. V; Bulkina, O. S; et al. (2006). Altered gene expression pattern in peripheral blood leukocytes from patients with arterial hypertension. Annals of the New York Academy of Sciences, 1091, 319-335. (Pubitemid 47092247)
24. Hitoshi, S; Ishino, Y; Kumar, A; Jasmine, S; Tanaka, K. F; Kondo, T; et al. (2011). Mammalian Gcm genes induce Hes5 expression by active DNA demethylation and induce neural stem cells. Nature Neuroscience, 14, 957-964.
25. van der Flier, L. G; van Gijn, M. E; Hatzis, P; Kujala, P; Haegebarth, A; Stange, D. E; et al. (2009). Transcription factor achaete scute-like 2 controls intestinal stem cell fate. Cell, 136, 903-912.
26. Schmidt-Lucke, C; Rossig, L; Fichtlscherer, S; Vasa, M; Britten, M; Kamper, U; et al. (2005). Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation, 111, 2981-2987. (Pubitemid 40814192)
27. Werner, N; Kosiol, S; Schiegl, T; Ahlers, P; Walenta, K; Link, A; et al. (2005). Circulating endothelial progenitor cells and cardiovascular outcomes. The New England Journal of Medicine, 353, 999-1007. (Pubitemid 41262334)
28. Briguori, C; Testa, U; Riccioni, R; Colombo, A; Petrucci, E; Condorelli, G; et al. (2010). Correlations between progression of coronary artery disease and circulating endothelial progenitor cells. The FASEB Journal, 24, 1981-1988.
29. Doney, A. S; Lee, S; Leese, G. P; Morris, A. D; & Palmer, C. N. (2005). Increased cardiovascular morbidity and mortality in type 2 diabetes is associated with the glutathione S transferase theta-null genotype: a Go-DARTS study. Circulation, 111, 2927-2934. (Pubitemid 40814185)
30. Ellis, K. L; Newton-Cheh, C; Wang, T. J; Frampton, C. M; Doughty, R. N; Whalley, G. A; et al. (2011). Association of genetic variation in the natriuretic peptide system with cardiovascular outcomes. Journal of Molecular and Cellular Cardiology, 50, 695-701.
31. Norskov, M. S; Frikke-Schmidt, R; Loft, S; Sillesen, H; Grande, P; Nordestgaard, B. G; et al. (2011). Copy number variation in glutathione S-transferases M1 and T1 and ischemic vascular disease: four studies and meta-analyses. Circulation. Cardiovascular Genetics, 4, 418-428.
32. Zacho, J; Tybjaerg-Hansen, A; Jensen, J. S; Grande, P; Sillesen, H; & Nordestgaard, B. G. (2008). Genetically elevated C-reactive protein and ischemic vascular disease. The New England Journal of Medicine, 359, 1897-1908.